S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Closing prices for crude oil, gold and other commodities
A gold storm is coming… (Ad)
MarketBeat Week in Review – 1/30 - 2/3
Ford, Starbucks fall; Clorox, Gilead Sciences rise
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
How major US stock indexes fared Friday 2/3/2023
A gold storm is coming… (Ad)
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Treasury makes more electric SUVs eligible for tax credits
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Closing prices for crude oil, gold and other commodities
A gold storm is coming… (Ad)
MarketBeat Week in Review – 1/30 - 2/3
Ford, Starbucks fall; Clorox, Gilead Sciences rise
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
How major US stock indexes fared Friday 2/3/2023
A gold storm is coming… (Ad)
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Treasury makes more electric SUVs eligible for tax credits
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Closing prices for crude oil, gold and other commodities
A gold storm is coming… (Ad)
MarketBeat Week in Review – 1/30 - 2/3
Ford, Starbucks fall; Clorox, Gilead Sciences rise
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
How major US stock indexes fared Friday 2/3/2023
A gold storm is coming… (Ad)
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Treasury makes more electric SUVs eligible for tax credits
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Closing prices for crude oil, gold and other commodities
A gold storm is coming… (Ad)
MarketBeat Week in Review – 1/30 - 2/3
Ford, Starbucks fall; Clorox, Gilead Sciences rise
A gold storm is coming… (Ad)
Skull found in '97 in remote Alaska belongs to New York man
How major US stock indexes fared Friday 2/3/2023
A gold storm is coming… (Ad)
Jury: Musk didn't defraud investors with 2018 Tesla tweets
Treasury makes more electric SUVs eligible for tax credits
NYSE:TFX

Teleflex - TFX Stock Forecast, Price & News

$258.47
-3.75 (-1.43%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$258.45
$264.25
50-Day Range
$224.49
$262.22
52-Week Range
$182.65
$356.72
Volume
476,926 shs
Average Volume
313,219 shs
Market Capitalization
$12.12 billion
P/E Ratio
29.64
Dividend Yield
0.52%
Price Target
$268.58

Teleflex MarketRank™ Forecast

Analyst Rating
Hold
2.45 Rating Score
Upside/​Downside
3.9% Upside
$268.58 Price Target
Short Interest
Healthy
2.10% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.36mentions of Teleflex in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
3.93%
From $12.98 to $13.49 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.21 out of 5 stars

Medical Sector

350th out of 1,028 stocks

Surgical & Medical Instruments Industry

34th out of 105 stocks

TFX stock logo

About Teleflex (NYSE:TFX) Stock

Teleflex, Inc. provides medical technology products which enables healthcare providers to improve patient outcomes and enhance patient and provider safety. The firm designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia (Asia Pacific) and OEM. The Americas segment engages in the sales of interventional urology products. The EMEA engages in the sales of urology products. The Asia segment designs, manufactures and distributes medical devices primarily used in critical care, surgical applications and cardiac care and generally serves hospitals and healthcare providers. The OEM segment designs, manufactures and supplies devices and instruments for other medical device manufacturers. The company was founded in 1943 and is headquartered in Wayne, PA.

Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

Teleflex (NYSE:TFX) Downgraded by StockNews.com to Hold
Teleflex (NYSE:TFX) PT Lowered to $260.00 at Truist Financial
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Brokerages Set Teleflex Incorporated (NYSE:TFX) PT at $279.62
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Return Trends At Teleflex (NYSE:TFX) Aren't Appealing
Should You Buy Teleflex Stock At $225?
Teleflex Expands Recalls Of Gibeck Iso-Gard Filters
Teleflex (TFX) Surpasses Q3 Earnings Estimates
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Company Calendar

Last Earnings
10/28/2021
Ex-Dividend for 12/15 Dividend
11/14/2022
Dividend Payable
12/15/2022
Today
2/04/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
87936910
Employees
14,000
Year Founded
1943

Price Target and Rating

Average Stock Price Forecast
$268.58
High Stock Price Forecast
$330.00
Low Stock Price Forecast
$210.00
Forecasted Upside/Downside
+3.9%
Consensus Rating
Hold
Rating Score (0-4)
2.45
Research Coverage
11 Analysts

Profitability

Net Income
$485.37 million
Pretax Margin
17.17%

Debt

Sales & Book Value

Annual Sales
$2.81 billion
Cash Flow
$18.38 per share
Book Value
$80.15 per share

Miscellaneous

Free Float
46,306,000
Market Cap
$12.12 billion
Optionable
Optionable
Beta
0.99

Social Links


Key Executives

  • Liam J. KellyLiam J. Kelly
    Chairman, President & Chief Executive Officer
  • Thomas E. Powell
    Chief Financial Officer & Executive Vice President
  • Justin McMurray
    VP-Global Strategic Research & Development
  • Timothy F. Duffy
    Chief Information Officer & Vice President
  • Michelle Fox
    Chief Medical Officer & Vice President













TFX Stock - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TFX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TFX, but not buy additional shares or sell existing shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price forecast for 2023?

11 brokerages have issued 12 month price targets for Teleflex's shares. Their TFX share price forecasts range from $210.00 to $330.00. On average, they predict the company's share price to reach $268.58 in the next twelve months. This suggests a possible upside of 3.9% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2023?

Teleflex's stock was trading at $249.63 at the beginning of 2023. Since then, TFX stock has increased by 3.5% and is now trading at $258.47.
View the best growth stocks for 2023 here
.

Are investors shorting Teleflex?

Teleflex saw a decrease in short interest in the month of January. As of January 15th, there was short interest totaling 982,800 shares, a decrease of 17.4% from the December 31st total of 1,190,000 shares. Based on an average trading volume of 398,100 shares, the days-to-cover ratio is presently 2.5 days.
View Teleflex's Short Interest
.

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our TFX earnings forecast
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its earnings results on Thursday, October, 28th. The medical technology company reported $3.51 EPS for the quarter, beating analysts' consensus estimates of $3.03 by $0.48. The medical technology company earned $700.25 million during the quarter, compared to analyst estimates of $698.25 million. Teleflex had a net margin of 14.76% and a trailing twelve-month return on equity of 16.26%. The business's revenue was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm posted $2.77 earnings per share.
Read the conference call transcript
.

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex announced a quarterly dividend on Thursday, October 27th. Shareholders of record on Tuesday, November 15th will be given a dividend of $0.34 per share on Thursday, December 15th. This represents a $1.36 annualized dividend and a yield of 0.53%. The ex-dividend date of this dividend is Monday, November 14th.
Read our dividend analysis for TFX
.

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.52%. The dividend payout ratio is 15.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 10.08% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (1.71%), Ceredex Value Advisors LLC (0.79%), Villere ST Denis J & Co. LLC (0.42%), Sarasin & Partners LLP (0.32%), Boston Trust Walden Corp (0.31%) and Sumitomo Mitsui Trust Holdings Inc. (0.28%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, James J Leyden, John Deren, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko and Stuart A Randle.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $258.47.

How much money does Teleflex make?

Teleflex (NYSE:TFX) has a market capitalization of $12.12 billion and generates $2.81 billion in revenue each year. The medical technology company earns $485.37 million in net income (profit) each year or $8.72 on an earnings per share basis.

How many employees does Teleflex have?

The company employs 14,000 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The official website for the company is www.teleflex.com. The medical technology company can be reached via phone at (610) 225-6800, via email at shareholder@broadridge.com, or via fax at 215-553-5402.

This page (NYSE:TFX) was last updated on 2/4/2023 by MarketBeat.com Staff